Dual responsive nanoparticle for brain targeted drug delivery
用于大脑靶向药物输送的双响应纳米颗粒
基本信息
- 批准号:8653312
- 负责人:
- 金额:$ 21.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Adverse effectsAlkanesAlzheimer&aposs DiseaseAmyloid beta-Protein PrecursorAttenuatedBlood - brain barrier anatomyBlood CirculationBrainBrain DiseasesCellsCentral Nervous System AgentsCentral Nervous System DiseasesChelating AgentsClioquinolDepositionDevelopmentDiseaseDrug Delivery SystemsDrug KineticsEncapsulatedEndothelial CellsEnsureEnvironmentEthylene GlycolsExhibitsFluorescent DyesGlioblastomaGlutathioneGoalsHepatolenticular DegenerationImageImmunohistochemistryIn VitroIonsKineticsLengthMalignant NeoplasmsMeasuresMetalsMicrodialysisModelingMolecular TargetMultiple SclerosisMusNanoGelNeurodegenerative DisordersNeuronsOxidation-ReductionParkinson DiseaseParticle SizePenetrationPenicillaminePharmaceutical PreparationsPhysiologicalPolyethylene GlycolsPolymersPropertyResearchResidual stateSJL MouseSenile PlaquesSignal TransductionStructureSymptomsSystemTg2576Therapeutic EffectToxic effectTransferrinTreatment EfficacyTumor TissueWaterbasebrain tissuecancer cellcomparative efficacycrosslinkdensitydityrosinedrug developmentefficacy testingethylene glycolextracellularin vivoinhibitor/antagonistmacromoleculemutantnanocarriernanoparticleoverexpressionreceptorsmall moleculesuccesstargeted deliverytherapeutic target
项目摘要
More than 98% of existing molecules cannot access the brain tissue because ofthe blood brain barrier (BBB). As a result, drugs that could be useful for central nervous system diseases cannot reach their targets efficiently and fail to exhibit acceptable therapeutic effect. The goal of the proposed research is to develop a highly selective and efficient system for drug delivery into the brain and to apply it to metal ion chelators that can solubilize AB aggregates and inhibit AB plaque formation associated with Alzheimer's disease. We hypothesize that by incorporating two targeting moieties into a pH and redox potential dual responsive nanogel, metal ion chelators, D-penicillamine (PA) and clioquinol (CQ) can be selectively targeted to the brain tissue and attenuate AB aggregation. Aim 1 is to develop a pH and redox potential dual responsive nanogel and explore the relationship between polymer structure and nanogel properties. In aim 2, we will load chelators or fluorescent dyes into dual targeted dual responsive nanogel (DTDR) with two braintargeting moieties (transferrin and glutathione) and measure DTDR efficacy and BBB penetration in vitro using a Transwell model. The neuroprotective effect of chelator-loaded DTDR will be compared with free drug counterparts and optimized by adjusting the densities of transferrin, glutathione, and polyethylene glycol. Aim 3 will assess the efficacy and BBB penetration of fluorescent dye or chelator-loaded brain-targeting DTDR in vivo. The composition of brain-targeted fluorescent DTDR will be optimized with IVIS imaging to achieve high selectivity for brain tissue in mice. The therapeutic efficacy of the brain-targeted PA or CQ-loaded DTDR will be quantified by measuring extracellular brain AB using in vivo microdialysis (IVM) in Tg2576 mice and compared with their free drug counterparts. Correlations between PA and CQ concentrations obtained from IVM, Zn and Cu residual in the brain tissue, amyloid plaque deposition from immunohistochemistry, and the residual AB in the brain tissue will be analyzed. Pharmacokinetic properties and systemic toxicity ofthe DTDR nanogel will also be evaluated. The success of this study should drastically increase the spectrum of drugs that can be developed for central nervous system diseases.
由于血脑屏障(blood brain barrier,BBB)的存在,超过98%的分子不能进入脑组织.因此,可用于中枢神经系统疾病的药物不能有效地到达它们的靶点,并且不能表现出可接受的治疗效果。拟议研究的目标是开发一种高度选择性和有效的系统,用于药物递送到大脑中,并将其应用于金属离子螯合剂,可以溶解AB聚集体并抑制与阿尔茨海默病相关的AB斑块形成。我们假设,通过将两个靶向部分并入pH和氧化还原电位双重响应纳米凝胶中,金属离子螯合剂D-青霉胺(PA)和氯碘羟喹(CQ)可以选择性地靶向脑组织并减弱AB聚集。目的一是制备pH和氧化还原电位双重响应的纳米凝胶,探讨聚合物结构与纳米凝胶性能的关系。在目标2中,我们将螯合剂或荧光染料负载到具有两个脑靶向部分(转铁蛋白和谷胱甘肽)的双靶向双响应纳米凝胶(DTDR)中,并使用Transwell模型在体外测量DTDR功效和BBB渗透。螯合剂负载DTDR的神经保护作用将与游离药物对应物进行比较,并通过调整转铁蛋白、谷胱甘肽和聚乙二醇的密度进行优化。目的3评价荧光染料或螯合剂负载的脑靶向DTDR的体内疗效和血脑屏障穿透性。脑靶向荧光DTDR的组成将通过IVIS成像进行优化,以实现对小鼠脑组织的高选择性。通过在Tg 2576小鼠中使用体内微透析(IVM)测量细胞外脑AB来量化脑靶向PA或CQ负载的DTDR的治疗功效,并与它们的游离药物对应物进行比较。将分析IVM获得的PA和CQ浓度、脑组织中的Zn和Cu残留、免疫组织化学获得的淀粉样斑块沉积以及脑组织中的残留AB之间的相关性。并对DTDR纳米凝胶的药代动力学特性和全身毒性进行评价。这项研究的成功将大大增加可用于中枢神经系统疾病的药物的范围。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peisheng Xu其他文献
Peisheng Xu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peisheng Xu', 18)}}的其他基金
Cancer cell selective killing nanoparticle for advanced ovarian cancer treatment
癌细胞选择性杀伤纳米颗粒用于晚期卵巢癌治疗
- 批准号:
10680585 - 财政年份:2022
- 资助金额:
$ 21.98万 - 项目类别:
Cancer cell selective killing nanoparticle for advanced ovarian cancer treatment
癌细胞选择性杀伤纳米颗粒用于晚期卵巢癌治疗
- 批准号:
10453919 - 财政年份:2022
- 资助金额:
$ 21.98万 - 项目类别:
The development of a multifunctional nanoenzyme for AD treatment
用于AD治疗的多功能纳米酶的开发
- 批准号:
10611675 - 财政年份:2022
- 资助金额:
$ 21.98万 - 项目类别:
Brain targeted nanoparticle for Alzheimer's disease therapy
用于治疗阿尔茨海默病的脑靶向纳米颗粒
- 批准号:
9329544 - 财政年份:2017
- 资助金额:
$ 21.98万 - 项目类别:
Nano-cocktail overcomes multidrug-resistance for ovarian cancer therapy
纳米鸡尾酒克服了卵巢癌治疗的多重耐药性
- 批准号:
8958102 - 财政年份:2015
- 资助金额:
$ 21.98万 - 项目类别:
Dual responsive nanoparticle for brain targeted drug delivery
用于大脑靶向药物输送的双响应纳米颗粒
- 批准号:
8885856 - 财政年份:
- 资助金额:
$ 21.98万 - 项目类别:
Dual responsive nanoparticle for brain targeted drug delivery
用于大脑靶向药物输送的双响应纳米颗粒
- 批准号:
9061734 - 财政年份:
- 资助金额:
$ 21.98万 - 项目类别:
相似海外基金
CAS: Supported Intermetallic Catalysts for Tandem Conversion of Light Alkanes and CO2
CAS:用于轻质烷烃和 CO2 串联转化的负载型金属间催化剂
- 批准号:
2400183 - 财政年份:2024
- 资助金额:
$ 21.98万 - 项目类别:
Standard Grant
CAREER: Binucleating Bis(pyrazolyl)alkanes for Tractable Bimetallic Polymerization
职业:双核双(吡唑基)烷烃用于易处理的双金属聚合
- 批准号:
2337696 - 财政年份:2024
- 资助金额:
$ 21.98万 - 项目类别:
Continuing Grant
CAREER: Real-time control of elementary catalytic steps: Controlling total vs partial electrocatalytic oxidation of alkanes and olefins
职业:实时控制基本催化步骤:控制烷烃和烯烃的全部与部分电催化氧化
- 批准号:
2338627 - 财政年份:2024
- 资助金额:
$ 21.98万 - 项目类别:
Continuing Grant
Developing Late Metal Catalytic Systems for Aerobic Partial Oxidation of Alkanes
开发烷烃有氧部分氧化的后金属催化系统
- 批准号:
2247667 - 财政年份:2023
- 资助金额:
$ 21.98万 - 项目类别:
Standard Grant
Activities of Rhodococcal cells in alkanes and application of their potentials induced by the environments
红球菌细胞在烷烃中的活性及其环境诱导潜力的应用
- 批准号:
23K18551 - 财政年份:2023
- 资助金额:
$ 21.98万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Collaborative Research: Rational design of Ni/Ga intermetallic compounds for efficient light alkanes conversion through ammonia reforming
合作研究:合理设计Ni/Ga金属间化合物,通过氨重整实现轻质烷烃的高效转化
- 批准号:
2210868 - 财政年份:2022
- 资助金额:
$ 21.98万 - 项目类别:
Standard Grant
Electrochemical fluorodecarboxylation for the labelling of gem-difluoro(cyclo)alkanes/amines
用于标记偕二氟(环)烷烃/胺的电化学氟脱羧
- 批准号:
EP/X02458X/1 - 财政年份:2022
- 资助金额:
$ 21.98万 - 项目类别:
Fellowship
Collaborative Research: Rational design of Ni/Ga intermetallic compounds for efficient light alkanes conversion through ammonia reforming
合作研究:合理设计Ni/Ga金属间化合物,通过氨重整实现轻质烷烃的高效转化
- 批准号:
2210760 - 财政年份:2022
- 资助金额:
$ 21.98万 - 项目类别:
Standard Grant
CAS: Synthetic Entries to ETM with M-Ligand Multiple Bonds and Their Role in Stoichiometric and Catalytic Carbon-Hydrogen Activation and Functionalization of Volatile Alkanes
CAS:具有 M 配体多重键的 ETM 合成条目及其在挥发性烷烃的化学计量和催化碳氢活化和官能化中的作用
- 批准号:
2154620 - 财政年份:2022
- 资助金额:
$ 21.98万 - 项目类别:
Standard Grant
Molecular dynamics study of linear alkanes geometrically restricted in carbon nanospaces
碳纳米空间几何限制的直链烷烃的分子动力学研究
- 批准号:
22K04866 - 财政年份:2022
- 资助金额:
$ 21.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)